WHO Drug Information, Vol. 19, No. 1, 2005                                                 Recommended INN: List 53



International Nonproprietary Names for
Pharmaceutical Substances (INN)
RECOMMENDED International Nonproprietary Names:
List 53
Notice is hereby given that, in accordance with paragraph 7 of the Procedure for the Selection of Recommended
International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org., 1955, 60, 3 (Resolution
EB15.R7); 1969, 173, 10 (Resolution EB43.R9)], the following names are selected as Recommended International
Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not
imply any recommendation of the use of the substance in medicine or pharmacy.
Lists of Proposed (1–91) and Recommended (1–52) International Nonproprietary Names can be found in Cumulative List
No. 11, 2004 (available in CD-ROM only).



Dénominations communes internationales
des Substances pharmaceutiques (DCI)
Dénominations communes internationales RECOMMANDÉES:
Liste 53
Il est notifié que, conformément aux dispositions du paragraphe 7 de la Procédure à suivre en vue du choix de
Dénominations communes internationales recommandées pour les Substances pharmaceutiques [Actes off. Org. mond.
Santé, 1955, 60, 3 (résolution EB15.R7); 1969, 173, 10 (résolution EB43.R9)] les dénominations ci-dessous sont choisies
par l’Organisation mondiale de la Santé en tant que dénominations communes internationales recommandées. L’inclusion
d’une dénomination dans les listes de DCI recommandées n’implique aucune recommandation en vue de l’utilisation de la
substance correspondante en médecine ou en pharmacie.
On trouvera d’autres listes de Dénominations communes internationales proposées (1–91) et recommandées (1–52) dans
la Liste récapitulative No. 11, 2004 (disponible sur CD-ROM seulement).



Denominaciones Comunes Internacionales
para las Sustancias Farmacéuticas (DCI)
Denominaciones Comunes Internacionales RECOMENDADAS:
Lista 53
De conformidad con lo que dispone el párrafo 7 del Procedimiento de Selección de Denominaciones Comunes
Internacionales Recomendadas para las Sustancias Farmacéuticas [Act. Of. Mund. Salud, 1955, 60, 3 (Resolución
EB15.R7); 1969, 173, 10 (Resolución EB43.R9)], se comunica por el presente anuncio que las denominaciones que a
continuación se expresan han sido seleccionadas como Denominaciones Comunes Internacionales Recomendadas. La
inclusión de una denominación en las listas de las Denominaciones Comunes Recomendadas no supone recomendación
alguna en favor del empleo de la sustancia respectiva en medicina o en farmacia.
Las listas de Denominaciones Comunes Internacionales Propuestas (1–91) y Recomendadas (1–52) se encuentran
reunidas en Cumulative List No. 11, 2004 (disponible sólo en CD-ROM).




                                                                                                                    69
Recommended INN: List 53                                             WHO Drug Information, Vol. 19, No. 1, 2005




 Latin, English, French, Spanish:
 Recommended INN                    Chemical name or description; Molecular formula; Graphic formula

 DCI Recommandée                    Nom chimique ou description; Formule brute; Formule développée

 DCI Recomendada                    Nombre químico o descripción; Fórmula empírica; Fórmula desarrollada




 abataceptum
 abatacept                                 1-25-oncostatin M (human precursor) fusion protein with CTLA-4
                                           (antigen) (human) fusion protein with immunoglobulin G1 (human
                                           heavy chain fragment), bimolecular (146→146')-disulfide

 abatacept                                 (146→146')-disulfure bimoléculaire de
                                               151     156    162    165   174
                                           [Gln ,Ser ,Ser ,Ser ,Ser ] (protéine de fusion entre le
                                           précurseur de l'oncostatine M humaine-(1-25)-peptide (séquence
                                           signal), la protéine 4 cytotoxique du lymphocyte-T humaine-[2-126]-
                                           peptide (partie extracellulaire de l'antigène CD152) et le peptide de
                                           233 résidus fragment C-terminal de la chaîne lourde de
                                           l'immunoglobuline G1 humaine)

 abatacept                                 1-25-oncostatina M (precursor humano) proteína da fusión con
                                           CTLA-4 (antígeno) (humano) proteína da fusión con
                                           inmunoglobulina G1 (fragmento humano de la pesada cadena),
                                           bimolecular (146→146')-disulfido

                                           C3750H5872N982O1154S38

                                             MGVLLTQRTL LSLVLALLFP SMASMAMHVA QPAVVLASSR
                                             GIASFVCEYA SPGKATEVRV TVLRQADSQV TEVCAATYMM
                                             GNELTFLDDS      ICTGTSSGNQ           *
                                                                                 VNLTIQGLRA         MDTGLYICKV
                                             ELMYPPPYYL         *
                                                             GIGNGTQIYV          IDPEPCPDSD         QEPKSSDKTH
                                             TSPPSPAPEL      LGGSSVFLFP          PKPKDTLMIS         RTPEVTCVVV
                                             DVSHEDPEVK      FNWYVDGVEV          HNAKTKPREE           *
                                                                                                    QYNSTYRVVS
                                             VLTVLHQDWL      NGKEYKCKVS          NKALPAPIEK         TISKAKGQPR
                                             EPQVYTLPPS      RDELTKNQVS          LTCLVKGFYP         SDIAVEWESN
                                             GQPENNYKTT      PPVLDSDGSF          FLYSKLTVDK         SRWQQGNVFS
                                             CSVMHEALHN      HYTQKSLSLS          PGK
                                                                                                                   2

                                                                    * glycosylation site
                                                                    * sites de glycosylation
                                                                    * posiciones de glicosilación




70
WHO Drug Information, Vol. 19, No. 1, 2005                                                   Recommended INN: List 53


 acotiamidum
 acotiamide                                  N-[2-[bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-
                                             4,5-dimethoxybenzoyl)amino]thiazol-4-carboxamide

 acotiamide                                  N-[2-[bis(1-méthyléthyl)amino]éthyl]-2-[(2-hydroxy-
                                             4,5-diméthoxybenzoyl)amino]thiazol-4-carboxamide

 acotiamida                                  N-[2-[bis(1-metiletil)amino]etil]-2-[(2-hidroxi-
                                             4,5-dimetoxibenzoil)amino]tiazol-4-carboxamida

                                             C21H30N4O5S

                                                                           O
                                                                                NH
                                                                                             CH3
                                                              O        N
                                                                                       N
                                             H3CO                                            CH3
                                                                   N       S    H 3C
                                                                   H                   CH3
                                             H3CO             OH




 alagebrium chloridum
 alagebrium chloride                         4,5-dimethyl-3-(2-oxo-2-phenylethyl)thiazolium chloride

 chlorure d'alagébrium                       chlorure de 4,5-diméthyl-3-(2-oxo-2-phényléthyl)thiazolium

 cloruro de alagebrio                        cloruro de 4,5-dimetil-3-(2-fenil-2-oxoetil)tiazolio

                                             C13H14ClNOS

                                                     S         O
                                             H3C         N+
                                                                               Cl-
                                                   H3C




 alglucosidasum alfa
 alglucosidase alfa                          human lysosomal prepro-α-glucosidase-(57-952)-peptide
                                             199-arginine-223-histidine variant

 alglucosidase alfa                          199-arginine-223-histidine variant du (57-952)-peptide de la prépro-
                                             α-glucosidase lysosomale humaine

 alglucosidasa alfa                          199-arginina-223-histidina variante del (57-952)-peptido de la
                                             prepro-α-glucosidasa lysosómica humana




                                                                                                                    71
Recommended INN: List 53                                WHO Drug Information, Vol. 19, No. 1, 2005


                           C4490H6823N1197O1298S32

                           QQGASRPGPR         DAQAHPGRPR         AVPTQCDVPP       NSRFDCAPDK
                           AITQEQCEAR         GCCYIPAKQG         LQGAQMGQPW       CFFPPSYPSY
                              *
                           KLENLSSSEM         GYTATLTRTT         PTFFPKDILT       LRLDVMMETE
                           NRLHFTIKDP         ANRRYEVPLE         TPRVHSRAPS       PLYSVEFSEE
                                                     *
                           PFGVIVHRQL         DGRVLLNTTV         APLFFADQFL       QLSTSLPSQY
                           ITGLAEHLSP         LMLSTSWTRI         TLWNRDLAPT       PGANLYGSHP
                           FYLALEDGGS         AHGVFLLNSN         AMDVVLQPSP       ALSWRSTGGI
                           LDVYIFLGPE         PKSVVQQYLD         VVGYPFMPPY       WGLGFHLCRW
                                                  *
                           GYSSTAITRQ         VVENMTRAHF         PLDVQWNDLD       YMDSRRDFTF
                           NKDGFRDFPA         MVQELHQGGR         RYMMIVDPAI       SSSGPAGSYR
                                                 *
                           PYDEGLRRGV         FITNETGQPL         IGKVWPGSTA       FPDFTNPTAL
                           AWWEDMVAEF         HDQVPFDGMW         IDMNEPSNFI       RGSEDGCPNN
                           ELENPPYVPG         VVGGTLQAAT         ICASSHQFLS       THYNLHNLYG
                           LTEAIASHRA         LVKARGTRPF         VISRSTFAGH       GRYAGHWTGD
                                                                                       *
                           VWSSWEQLAS         SVPEILQFNL         LGVPLVGADV       CGFLGNTSEE
                           LCVRWTQLGA         FYPFMRNHNS         LLSLPQEPYS       FSEPAQQAMR
                           KALTLRYALL         PHLYTLFHQA         HVAGETVARP       LFLEFPKDSS
                           TWTVDHQLLW         GEALLITPVL         QAGKAEVTGY       FPLGTWYDLQ
                           TVPIEALGSL         PPPPAAPREP         AIHSEGQWVT       LPAPLDTINV
                           HLRAGYIIPL         QGPGLTTTES         RQQPMALAVA       LTKGGEARGE
                           LFWDDGESLE         VLERGAYTQV              *
                                                                 IFLARNNTIV       NELVRVTSEG
                                                                         *
                           AGLQLQKVTV         LGVATAPQQV         LSNGVPVSNF       TYSPDTKVLD
                           ICVSLLMGEQ         FLVSWC
                                                  * glycosylation sites
                                                  * sites de glycosylation
                                                  * posiciones de glicosilación




 armodafinilum
 armodafinil               2-[(R)-(diphenylmethyl)sulfinyl]acetamide

 armodafinil               (-)-2-[(R)-(diphénylméthyl)sulfinyl]acétamide

 armodafinilo              (-)-2-[(R)-(difenilmetil)sulfinil]acetamida

                           C15H15NO2S

                                        O     O
                                        S
                                                  NH2




72
WHO Drug Information, Vol. 19, No. 1, 2005                                                 Recommended INN: List 53


 bamirastinum
 bamirastine                                 2-[6-({3-[4-(diphenylmethoxy)piperidin-1-yl]propyl}amino)imidazo=
                                             [1,2-b]pyridazin-2-yl]-2-methylpropanoic acid

 bamirastine                                 acide 2-[6-[[3-[4-(diphénylméthoxy)pipéridin-1-yl]propyl]amino]=
                                             imidazo[1,2-b]pyridazin-2-yl]-2-méthylpropanoïque

 bamirastina                                 ácido 2-[6-[[3-[4-(difenilmetoxi)piperidin-1-il]propil]amino]imidazo=
                                             [1,2-b]piridazin-2-il]-2-metilpropanoico

                                             C31H37N5O3

                                                                                               N     CO2H

                                                                                           N         CH3
                                                                    N           N      N           CH3
                                                                                H
                                                          O




 befetupitantum
 befetupitant                                2-[3,5-bis(trifluomethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-
                                             6-(morpholin-4-yl)pyridin-3-yl]propanamide

 béfétupitant                                2-[3,5-bis(trifluométhyl)phényl]-N,2-diméthyl-N-[4-(2-méthylphényl)-
                                             6-(morpholin-4-yl)pyridin-3-yl]propanamide

 befetupitant                                2-[3,5-bis(trifluometil)fenil]-N,2-dimetil-N-[4-(2-metilfenil)-6-(morfolin-
                                             4-il)piridin-3-il]propanamida

                                             C29H29F6N3O2

                                             O                               CF3
                                                    N     N
                                                                    O

                                                                N                   CF3
                                                                          CH3
                                                 H3C            CH3     CH3




 belotecanum
 belotecan                                   (4S)-4-ethyl-4-hydroxy-11-[2-(isopropylamino)ethyl]-1,12-dihydro-
                                             14H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione

 bélotécan                                   (4S)-4-éthyl-4-hydroxy-11-[2-[(1-méthyléthyl)amino]éthyl]-
                                             1,12-dihydro-14H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoléine-
                                             3,14(4H)-dione

 belotecán                                   (4S)-4-etil-4-hidroxi-11-[2-(isopropilamino)etil]-1,12-dihidro-
                                             14H-pirano[3’,4’:6,7]indolizino[1,2-b]quinolina-3,14(4H)-diona




                                                                                                                           73
Recommended INN: List 53                               WHO Drug Information, Vol. 19, No. 1, 2005


                           C25H27N3O4

                           H3C                             O
                                   NH
                            H3C                        N            O

                                                                        O
                                                   N           HO       CH3




 carmoterolum
 carmoterol                8-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-
                           1-methylethyl]amino}ethyl]quinolin-2(1H)-one

 carmotérol                8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-méthoxyphényl)-
                           1-méthyléthyl]amino]éthyl]quinoléin-2(1H)-one

 carmoterol                8-hidroxi-5-[(1R)-1-hidroxi-2-[[(1R)-2-(4-metoxifenil)-propan-
                           2-il]amino]etil]quinolin-2(1H)-ona

                           C21H24N2O4

                                        H OH H
                                             N

                                                   H CH3
                           HO                                       OCH3
                                  HN

                                       O



 cetilistatum
 cetilistat                2-(hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one

 cétilistat                2-(hexadécyloxy)-6-méthyl-4H-3,1-benzoxazin-4-one

 cetilistat                2-(hexadeciloxi)-6-metil-4H-3,1-benzoxazin-4-ona

                           C25H39NO3

                                           N       O                                         CH3

                                               O
                           H3C
                                           O



 dasantafilum
 dasantafil                7-(3-bromo-4-methoxyphenylmethyl)-1-ethyl-8-{[(1R,2R)-
                           2-hydroxycyclopropyl]amino}-3-(2-hydroxyethyl)-3,7-dihydro-
                           1H-purine-2,6-dione

 dasantafil                7-(3-bromo-4-méthoxybenzyl)-1-éthyl-8-[[(1R,2R)-
                           2-hydroxycyclopentyl]amino]-3-(2-hydroxyéthyl)-3,7-dihydro-
                           1H-purine-2,6-dione

 dasantafilo               7-(3-bromo-4-metoxibencil)-1-etil-8-[[(1R,2R)-2-hidroxiciclopentil]=
                           amino]-3-(2-hidroxietil)-3,7-dihidro-1H-purina-2,6-diona



74
WHO Drug Information, Vol. 19, No. 1, 2005                                                        Recommended INN: List 53


                                             C22H28BrN5O5

                                                                                      Br

                                                            O
                                                                                           OCH3
                                                                    N
                                             H3C        N
                                                                          NH H
                                                   O        N       N                 H
                                                                    OH                OH




 deluceminum
 delucemine                                  3,3-bis(3-fluorophenyl)-N-methylpropan-1-amine

 délucémine                                  3,3-bis(3-fluorophényl)-N-méthylpropan-1-amine

 delucemina                                  3,3-bis(3-fluorofenil)-N-metilpropan-1-amina

                                             C18H27N5O21P4


                                                                    H
                                                                    N
                                             F                          CH3




                                                                F




 denufosolum
 denufosol                                   2'-deoxycytidine(5')tetraphospho(5')uridine

 dénufosol                                   2'-désoxycytidine(5')tétraphospho(5')uridine

 denufosol                                   2'-desoxicitidina(5')tetrafosfo(5')uridina

                                             C18H27N5O21P4

                                                        HO O                          H
                                                          P                   O       N      O
                                                        O   O
                                                     P O      O                   N
                                                    O
                                                      OH
                                                  P O
                                                O         HO                  OH
                                                    OH
                                             O P         O    N                NH2
                                                  O
                                             HO
                                                       O    N


                                                       HO




                                                                                                                       75
Recommended INN: List 53                                 WHO Drug Information, Vol. 19, No. 1, 2005


 depelestatum
 depelestat                human recombinant neutrophil elastase inhibitor, homologue of the
                           second Kunitz domain of Inter-alpha-trypsin inhibitor light chain:
                               285  297    300   301    302
                           [Glu ,Ile ,Phe ,Pro ,Arg ]AMBP protein
                           precursor-(285-340)-peptide (human)
                                 285   297       300   301        302
 dépélestat                [Glu ,Ile ,Phe ,Pro ,Arg ]précurseur de la protéine AMBP
                           humaine-(285-340)-peptide, homologue du second domaine Kunitz
                           de la chaîne légère de l’inhibiteur de l’Inter-alpha-trypsine, inhibiteur
                           de l’élastase neutrophile
                                 285   297       300   301        302
 depelestat                [Glu ,Ile ,Phe ,Pro ,Arg ]precursor de la proteína AMBP
                           humana-(285-340)-péptido, homólogo del segundo dominio Kunitz
                           de la cadena ligera del inhibidor de la Inter-alfa-tripsina, inhibidor de
                           la elastasa neutrófila

                           C282H412N74O75S6

                           H Glu Ala Cys Asn Leu Pro Ile Val Arg Gly Pro Cys Ile Ala
                               3                                        10
                              Phe Phe Pro Arg Trp Ala Phe Asp Ala Val Lys Gly Lys Cys
                                                  20                                        30
                              Val Leu Phe Pro Tyr Gly Gly Cys Gln Gly Asn Gly Asn Lys
                                                                                 40
                              Phe Tyr Ser Glu Lys Glu Cys Arg Glu Tyr Cys Gly Val Pro OH
                                                             50




 dirlotapidum
 dirlotapide               N-{(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-
                           5-[4'-(trifluoromethyl)biphenyl-2-carboxamido]-1H-indol-
                           2-carboxamide

 dirlotapide               N-[(1S)-2-(benzylméthylamino)-2-oxo-1-phényléthyl]-1-méthyl-
                           5-[[[4'-(trifluorométhyl)biphényl-2-yl]carbonyl]amino]-1H-indole-
                           2-carboxamide

 dirlotapida               N-[(1S)-2-(bencilmetilamino)-2-oxo-1-feniletil]-1-metil-
                           5-[[[4'-(trifluorometil)bifenil-2-il]carbonil]amino]-1H-indol-
                           2-carboxamida

                           C40H33F3N4O3




                                                       H3C          O            CH3
                                                                             H
                                                         N                       N
                                                                        N
                           F3C                                          H
                                                                             O
                                             O
                                                  NH




76
WHO Drug Information, Vol. 19, No. 1, 2005                                                Recommended INN: List 53


 edaglitazonum
 edaglitazone                                (5RS)-5-({4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-
                                             1-benzothiophen-7-yl}methyl)-1,3-thiazolidine-2,4-dione

 édaglitazone                                (5RS)-5-[[4-[2-(5-méthyl-2-phényloxazol-4-yl)éthoxy]-
                                             1-benzothiophén-7-yl]méthyl]thiazolidine-2,4-dione

 edaglitazona                                (5RS)-5-[[4-[2-(2-fenil-5-metiloxazol-4-il)etoxi]-1-benzotiofen-
                                             7-il]metil]tiazolidina-2,4-diona

                                             C24H20N2O4S2

                                                                                          O
                                                           N           O
                                                                                      S       and enantiomer
                                                                                           NH et énantiomère
                                                           O                                  y enantiómero
                                                                CH3
                                                                                      H   O
                                                                            S

 eslicarbazepinum
 eslicarbazepine                             (10S)-10-hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepin-
                                             5-carboxamide

 eslicarbazépine                             (10S)-10-hydroxy-10,11-dihydro-5H-dibenzo[b,f]azépin-
                                             5-carboxamide

 eslicarbazepina                             (10S)-10-hidroxi-10,11-dihidro-5H-dibenzo[b,f]azepin-5-carboxamida

                                             C15H14N2O2


                                                           O

                                                       N       NH2


                                             HO
                                                  H


 exbivirumabum
 exbivirumab                                 immunoglobulin G, anti-(hepatitis B surface antigen) (human
                                             monoclonal 19.79.5 heavy chain), disulfide with human monoclonal
                                             19.79.5 λ chain, dimer

 exbivirumab                                 immunoglobuline G, anti-(antigène de surface du virus de
                                             l'hépatite B) dimère du disulfure entre la chaîne lourde et la chaîne λ
                                             de l'anticorps monoclonal humain 19.79.5

 exbivirumab                                 inmunoglobulina G, anti-(antígeno de superficie del virus de la
                                             hepatitis B) dímero del disulfuro entre la cadena pesada y la
                                             cadena λ del anticuerpo monoclonal humano 19.79.5

                                             C6416H9924N1732O1982S44




                                                                                                                   77
Recommended INN: List 53                                           WHO Drug Information, Vol. 19, No. 1, 2005


 fampronilum
 fampronil                 2-{5-chloro-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-3-methyl-
                           1H-pyrazol-4-yl}-1H-imidazole-4,5-dicarbonitrile

 fampronil                 2-[5-chloro-1-[2,6-dichloro-4-(trifluorométhyl)phényl]-3-méthyl-
                           1H-pyrazol-4-yl]-1H-imidazole-4,5-dicarbonitrile

 fampronilo                2-[5-cloro-1-[2,6-dicloro-4-(trifluorometil)fenil]-3-metil-1H-pirazol-4-il]-
                           1H-imidazol-4,5-dicarbonitrilo

                           C16H6Cl3F3N6

                                                              CH3
                                       Cl
                                                 N
                                             N                      N        CN

                           F3C                                 HN
                                                     Cl
                                            Cl                              CN



 fidexabanum
 fidexaban                 {[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-{3-[1-methyl-
                           4,5-dihydro-1H-imidazol-2-yl]phenoxy}pyridin-4-yl]methylamino}=
                           acetic acid

 fidexaban                 acide [[2-(5-carbamimidoyl-2-hydroxyphénoxy)-3,5-difluoro-
                           6-[3-(1-méthyl-4,5-dihydro-1H-imidazol-2-yl)phénoxy]pyridin-
                           4-yl]méthylamino]acétique

 fidexabán                 ácido [[2-(5-carbamimidoil-2-hidroxifenoxi)-3,5-difluoro-6-[3-(1-metil-
                           4,5-dihidro-1H-imidazol-2-il)fenoxi]piridin-4-il]metilamino]acético

                           C25H24F2N6O5

                                  NH                           F        CH3
                                                 O                      N        CO2H
                           H2 N
                                                          N
                                                 OH                     F        N
                                                               O
                                                                                     N
                                                                                     CH3




 fingolimodum
 fingolimod                2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol

 fingolimod                2-amino-2-[2-(4-octylphényl)éthyl]propane-1,3-diol

 fingolimod                2-amino-2-[2-(4-octilfenil)etil]propano-1,3-diol

                           C19H33NO2

                                                                                         OH
                                                                                          NH2
                                                                                                OH

                           H3C




78
WHO Drug Information, Vol. 19, No. 1, 2005                                                                                 Recommended INN: List 53


 gadodenteratum
 gadodenterate                               10,10',10",10''',10'''',10''''',10'''''',10''''''',10'''''''',10''''''''',10'''''''''',10''''''''''',
                                             10'''''''''''',10''''''''''''',10'''''''''''''',10''''''''''''''',10'''''''''''''''',10''''''''''''''''',10'''''''''''''''''',
                                             10''''''''''''''''''',10'''''''''''''''''''',10''''''''''''''''''''',10'''''''''''''''''''''',10'''''''''''''''''''''''-
                                             (benzene-1,3,5-triyltris(carbonylnitrilobis{(ethan-2,1-diylimino)
                                             [(5S)-6-oxohexane-6,1,5-triyl]bis(imino[(5S)-6-oxohexane-
                                             6,1,5-triyl]bis{(2-oxoethane-2,1-diyl)imino[(2S)-1-oxopropane-
                                             1,2-diyl]})]})}tetracosakis[1,4,7,10-tetraazacyclodecane-
                                             1,4,7-triacetato(3–)gadolinium(III)]

 gadodentérate                               10,10',10'',10''',10'''',10''''',10'''''',10''''''',10'''''''',10''''''''',10'''''''''',10''''''''''',
                                             10'''''''''''',10''''''''''''',10'''''''''''''',10''''''''''''''',10'''''''''''''''',10''''''''''''''''',10'''''''''''''''''',
                                             10''''''''''''''''''',10'''''''''''''''''''',10''''''''''''''''''''',10'''''''''''''''''''''',10'''''''''''''''''''''''-
                                             [benzène-1,3,5-triyltris[carbonylnitrilobis[éthylèneimino=
                                             [(5S)-6-oxohexane-6,1,5-triyl]bis[imino[(5S)-6-oxohexane-
                                             6,1,5-triyl]bis[imino(2-oxoéthylène)imino(1-méthyl-
                                             2-oxoéthylène)]]]]]tétracosakis[[1,4,7,10-tétraazacyclododécane-
                                             1,4,7-triacétato(3-)]gadolinium]

 gadodenterato                               10,10',10",10''',10'''',10''''',10'''''',10''''''',10'''''''',10''''''''',10'''''''''',10''''''''''',
                                             10'''''''''''',10''''''''''''',10'''''''''''''',10''''''''''''''',10'''''''''''''''',10''''''''''''''''',10'''''''''''''''''',
                                             10''''''''''''''''''',10'''''''''''''''''''',10''''''''''''''''''''',10'''''''''''''''''''''',10'''''''''''''''''''''''-
                                             [benceno-1,3,5-triiltris[carbonilnitrilobis[etilenoimino=
                                             [(5S)-6-oxohexano-6,1,5-triil]bis[imino[(5S)-6-oxohexano-
                                             6,1,5-triil]]bis[imino(2-oxoetileno)imino(1-metil-
                                             2-oxoetileno)]]]]tetracosakis[[1,4,7,10-tetraazaciclododecano-
                                             1,4,7-triacetato(3-)]gadolinio]

                                             C585H927Gd24N165O213

                                                                                                      R       H
                                                                                                                    O
                                                                               R                                                            R     H
                                                                                                              NH                      O
                                                                     R      H                                                                                             R
                                                                                   H
                                                                                   N                                                       NH
                                             R                                                     N                     O
                                                                               O
                                                                                              O                                 N

                                                                           R       H     H                                                  R     H
                                                                                         N                                        HN
                                                    R                                                     N         O                                                     R
                                                                                   O                                                      O
                                                                                    R H
                                                                                                                            -
                                                                                                   NH                           O2C                                  CO 2-
                                                             R                                                                              N              N
                                                                                              O                                                    Gd3+

                                                                                                                                            N              N
                                                                                                                                                                     CO2-
                                                                                                                             H3C
                                               -
                                                                                                                                                  O
                                                   O2C                                  CO2-
                                                               N               N                                                      HN

                                                                      Gd3+
                                                                                                                                 O
                                               -               N               N                       O                              H NH H
                                                   O2C                                       H
                                                                                             N                                             N                   = R-
                                                                                                              N
                                                                       H 3C                                   H
                                                                                       O                                                      O




                                                                                                                                                                              79
Recommended INN: List 53                                 WHO Drug Information, Vol. 19, No. 1, 2005


 gantacurium chloridum
 gantacurium chloride      (1R,2S)-2-(3-{[(2Z)-2-chloro-4-{3-[(1S,2R)-6,7-dimethoxy-2-methyl-
                           1-(3,4,5-trimethoxyphenyl)-1,2,3,4-tetrahydroisoquinolinium-
                           2-yl]propoxy}-4-oxobut-2-enoyl]oxy}propyl)-6,7-dimethoxy-2-methyl-
                           1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolinium
                           dichloride

 chlorure de gantacurium   dichlorure de (1R,2S)-2-[3-[[(2Z)-2-chloro-4-[3-[(1S,2R)-6,7-
                           diméthoxy-2-méthyl-1-(3,4,5-triméthoxyphényl)-1,2,3,4-
                           tétrahydroisoquinoléinio]propoxy]-4-oxobut-2-énoyl]oxy]propyl]-
                           6,7-diméthoxy-2-méthyl-1-(3,4,5-triméthoxybenzyl)-
                           1,2,3,4-tétrahydroisoquinoléinium

 cloruro de gantacurio     dicloruro de (1R,2S)-2-[3-[[(2Z)-2-cloro-4-[3-[(1S,2R)-2-metil-
                           6,7-dimetoxi-1-(3,4,5-trimetoxifenil)-1,2,3,4-tetrahidroisoquinolinio]=
                           propoxi]-4-oxobut-2-enoil]oxi]propil]-2-metil-6,7-dimetoxi-
                           1-(3,4,5-trimetoxibencil)-1,2,3,4-tetrahidroisoquinolinio

                           C53H69Cl3N2O14

                                    OCH3
                                                                                     Cl-
                           H3CO                                                                          OCH3
                                                             O
                                                                               H3C    +
                                                                          O          N
                           H3CO                          O                                               OCH3
                                       H                                                     H
                           H3CO                                  Cl   O
                                             N+
                                                   CH3
                           H3CO                                               H3CO                OCH3
                                             Cl-
                                                                                           OCH3




 golimumabum
 golimumab                 immunoglobulin G1, anti-(human tumor necrosis factor α) (human
                           monoclonal CNTO 148 γ1-chain), disulfide with human monoclonal
                           CNTO 148 κ-chain, dimer

 golimumab                 immunoglobuline G1, anti-(facteur α de nécrose tumorale humain)
                           dimère du disulfure entre la chaîne γ1 et la chaîne κ de l'anticorps
                           monoclonal humain CNTO 148

 golimumab                 inmunoglobulina G1, anti-(factor α de necrosis tumoral humano)
                           dímero del disulfuro entre la cadena γ1 y la cadena κ del anticuerpo
                           monoclonal humano CNTO 148

                           C6530H10068N1752O2026S44




 idronoxilum
 idronoxil                 3-(4-hydroxyphenyl)-2H-chromen-7-ol

 idronoxil                 3-(4-hydroxyphényl)-2H-1-benzopyran-7-ol

 idronoxilo                3-(4-hidroxifenil)-2H-1-benzopiran-7-ol




80
WHO Drug Information, Vol. 19, No. 1, 2005                                                   Recommended INN: List 53


                                             C15H12O3

                                                                           OH




                                             HO             O



 imiglitazarum
 imiglitazar                                 (4E)-4-[({4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl}=
                                             methoxy)imino]-4-phenylbutanoic acid

 imiglitazar                                 acide (4E)-4-[[[4-[(5-méthyl-2-phényloxazol-4-yl)méthoxy]benzyl]=
                                             oxy]imino]-4-phénylbutanoïque

 imiglitazar                                 ácido (4E)-4-[[[4-[(2-fenil-5-metiloxazol-4-il)metoxi]bencil]oxi]imino]-
                                             4-fenilbutanoico

                                             C28H26N2O5



                                                                                        N
                                                                                   O

                                                            N
                                                                   O
                                                                                               CO2H
                                                            O   CH3



 indacaterolum
 indacaterol                                 5-{(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]
                                             -1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one

 indacatérol                                 5-[(1R)-2-[(5,6-diéthyl-2,3-dihydro-1H-indén-2-yl)amino]-
                                             1-hydroxyéthyl]-8-hydroxyquinoléin-2(1H)-one

 indacaterol                                 5-[(1R)-2-[(5,6-dietil-2,3-dihidro-1H-inden-2-il)amino]-1-hidroxietil]-
                                             8-hidroxiquinolin-2(1H)-ona

                                             C24H28N2O3

                                                          H OH H
                                                               N
                                                                                       CH3
                                             HO
                                                   HN
                                                                                   CH3
                                                        O



 indibulinum
 indibulin                                   2-[1-(4-chlorophenylmethyl)-1H-indol-3-yl]-2-oxo-N-(pyridin-
                                             4-yl)acetamide

 indibuline                                  2-[1-(4-chlorobenzyl)-1H-indol-3-yl]-2-oxo-N-(pyridin-4-yl)acétamide

 indibulina                                  2-[1-(4-clorobencil)-1H-indol-3-il]-2-oxo-N-(piridin-4-il)acetamida



                                                                                                                        81
Recommended INN: List 53                               WHO Drug Information, Vol. 19, No. 1, 2005


                           C22H16ClN3O2

                                                   O
                                                           H
                                                           N
                                        N
                                                       O          N



                           Cl

 ismomultinum alfa
 ismomultin alfa           47-261-Glycoprotein gp 39 (human clone CDM8-gp39 reduced)

 ismomultine alfa          [290-isoleucine]glycoprotéine 39 constituant du cartilage humain
                           (glycoforme alfa)

 ismomultina alfa          fragmento 47-261 de la glicoproteina 39 constituyente del cartílago
                                                124
                           humano (variante [Arg ] producida por el clon humano CDM8-
                           gp39)


                           C1827H2785N493O530S11

                                                                                           *
                           YKLVCYYTSW       SQYREGDGSC           FPDALDRFLC        THIIYSFANI
                           SNDHIDTWEW       NDVTLYGMLN           TLKNRNPNLK        TLLSVGGWNF
                           GSQRFSKIAS       NTQSRRTFIK           SVPPFLRTHG        FDGLDLAWLY
                           PGRRDKQHFT       TLIKEMKAEF           IKEAQPGKKQ        LLLSAALSAG
                           KVTIDSSYDI       AKISQHLDFI           SIMTYDFHGA        WRGTTGHHSP
                           LFRGQEDASP       DRFSNTDYAV           GYMLRLGAPA        SKLVMGIPTF
                           GRSFTLASSE       TGVGAPISGP           GIPGRFTKEA        GTLAYYEICD
                           FLRGATVHRI       LGQQVPYATK           GNQWVGYDDQ        ESVKSKVQYL
                           KDRQLAGAMV       WALDLDDFQG           SFCGQDLRFP        LTNAIKDALA
                           AT
                                                   * glycosylation site
                                                   * sites de glycosylation
                                                   * posiciones de glicosilación


 lanimostimum
 lanimostim                4-221-colony-stimulating factor 1 (human clone p3ACSF-69
                           reduced)

 lanimostim                facteur-1 de stimulation de colonie de macrophage humain-(4-221)-
                           peptide (clone humain p3ACSF-69)

 lanimostim                factor-1 de la estímulo de colonia de macrófago humano -(4-221)-
                           péptido (clon humano p3ACSF-69)

                           C2146H3346N572O686S28

                               SEYCSHM       IGSGHLQSLQ          RLIDSQMETS        CQITFEFVDQ
                            EQLKDPVCYL       KKAFLLVQDI          MEDTMRFRDN        TPNAIAIVQL
                            QELSLRLKSC       FTKDYEEHDK          ACVRTFYETP        LQLLEKVKNV
                            FNETKNLLDK       DWNIFSKNCN          NSFAECSSQD        VVTKPDCNCL
                            YPKAIPSSDP       ASVSPHQPLA          PSMAPVAGLT        WEDSEGTEGS
                            SLLPGEQPLH       TVDPGSAKQR          P
                                                                                                2



82
WHO Drug Information, Vol. 19, No. 1, 2005                                                         Recommended INN: List 53




 lemuteporfinum
                                                                  1
 lemuteporfin                                dimethyl (2RS,2 SR)-8-ethenyl-13,17-bis=
                                             [3-(2-hydroxyethoxycarbonyl)-3-oxopropyl]-2,7,12,18-tetramethyl-
                                                 1                          1 2
                                             2,2 -dihydrobenzo[b]porphyrin-2 ,2 -dicarboxylate

 lémutéporfine                               trans-8-éthényl-13,17-bis[3-(2-hydroxyéthoxy)-3-oxopropyl]-
                                                                       1
                                             2,7,12,18-tétraméthyl-2,2 -dihydrobenzo[b]porphyrine-
                                               1 2
                                             2 ,2 -dicarboxylate de diméthyle

 lemuteporfina                               trans-8-etenil-13,17-bis[3-(2-hidroxietoxi)-3-oxopropil]-
                                                                     1                           1 2
                                             2,7,12,18-tetrametil-2,2 -dihidrobenzo[b]porfirine-2 ,2 -dicarboxylate
                                             de dimetilo

                                             C44H48N4O10

                                                                                             O O     O
                                                                                 H3C
                                                          O                            O                 CH3
                                                                          H3C          H3C
                                                        O
                                             HO
                                                                                 N     HN


                                                                                 NH     N
                                             HO
                                                        O                                          CH3

                                                                          H 3C
                                                          O                                    CH2




 lenalidomidum
 lenalidomide                                (3RS)-3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-
                                             2,6-dione

 lénalidomide                                (3RS)-3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pipéridine-
                                             2,6-dione

 lenalidomide                                (3RS)-3-(4-amino-1-oxo-1,3-dihidro-2H-isoindol-2-il)piperidina-
                                             2,6-diona

                                             C13H13N3O3

                                                        O                    O
                                                                                 and enantiomer
                                                         N                NH     et énantiomère
                                                              H                  y enantiómero
                                                                      O
                                                NH2




                                                                                                                        83
Recommended INN: List 53                                 WHO Drug Information, Vol. 19, No. 1, 2005


 lestaurtinibum
 lestaurtinib              (9S,10S,12R)-10-hydroxy-10-(hydroxymethyl)-9-methyl-2,3,9,10,11,12-
                           hexahydro-1H-9,12-epoxydiindolo[1,2,3-fg:3',2',1'-kl]pyrrolo=
                           [3,4-i][1,6]benzodiazocin-1-one

 lestaurtinib              (9S,10S,12R)-10-hydroxy-10-(hydroxyméthyl)-9-méthyl-2,3,9,10,11,12-
                           hexahydro-9,12-époxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo=
                           3,4-i][1,6]benzodiazocin-1-one

 lestaurtinib              (9S,10S,12R)-10-hidroxi-10-(hidroximetil)-9-metil-2,3,9,10,11,12-
                           hexahidro-9,12-epoxi-1H-diindolo[1,2,3-fg:3',2',1'-kl]pirrolo=
                           [3,4-i][1,6]benzodiazocin-1-ona

                           C26H21N3O4

                                          H
                                  O       N




                                      N        N
                                          O
                                 H                 CH3
                                                    OH
                                              OH



 libivirumabum
 libivirumab               immunoglobulin G, anti- (hepatitis B surface antigen)(human
                           monoclonal 17.1.41 heavy chain), disulfide with human monoclonal
                           17.1.41 κ-chain, dimer

 libivirumab               immunoglobuline G, anti-(antigène de surface du virus de
                           l'hépatite B) ; dimère du disulfure entre la chaîne lourde et la
                           chaîne κ de l'anticorps monoclonal humain 17.1.41

 libivirumab               inmunoglobulina G, anti-(antígeno de superficie del virus de la
                           hepatitis B) ; dímero del disulfuro entre la cadena pesada y la
                           cadena κ del anticuerpo monoclonal humano 17.1.41

                           C6598H10232N1788O2060S46




 maravirocum
 maraviroc                 isopropyl, 4,4-difluoro-N-[(1S)-3-{(1R,3s,5S)-3-[3-methyl-5-(propan-
                           2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-
                           1-phenylpropyl]cyclohexanecarboxamide

 maraviroc                 4,4-difluoro-N-[(1S)-3-[(1R,3s,5S)-3-[3-méthyl-5-(1-méthyléthyl)-
                           4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phénylpropyl]=
                           cyclohexanecarboxamide

 maraviroc                 4,4-difluoro-N-[(1S)-1-fenil-3-[(1R,3s,5S)-3-[3-isopropil-5-metil-
                           4H-1,2,4-triazol-4-il]-8-azabiciclo[3.2.1]oct-8-il] propil]=
                           ciclohexanocarboxamida




84
WHO Drug Information, Vol. 19, No. 1, 2005                                                   Recommended INN: List 53


                                             C29H41F2N5O

                                                                                           CH3
                                                                               H3C
                                                 F                     H           H
                                                                                            N
                                             F                                         N
                                                             H                              N
                                                             N             N
                                                                                   H3C
                                                         O    H                H




 mecaserminum rinfabas
 mecasermin rinfabate                        insulin-like growth factor I (human), complex with insulin-like growth
                                             factor-binding protein IGFBP-3 (human)

 mécasermine rinfabate                       facteur I de croissance humain analogue à l'insuline (mécasermine)
                                             lié à la [5-alanine]protéine-3 humaine se liant au facteur de
                                             croissance analogue à l'insuline (IGFBP-3 humaine)

 mecasermina rinfabato                       factor I del crecimiento humano semejante a la insulina
                                             (mecasermina) unida a la [5-alanina]proteína-3 humana unida con el
                                             factor de crecimiento similar a la insulina (IGFBP-3 humana)

                                             C1231H1967N371O384S20

                                                 GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ
                                                 TGIVDECCFR SCDLRRLEMY CAPLKPAKSA
                                                 GASSAGLGPV       VRCEPCDARA         LAQCAPPPAV      CAELVREPGC
                                                 GCCLTCALSE       GQPCGIYTER         CGSGLRCQPS      PDEARPLQAL
                                                 LDGRGLCVNA       SAVSRLRAYL         LPAPPAPGNA      SESEEDRSAG
                                                 SVESPSVSST       HRVSDPKFHP         LHSKIIIIKK      GHAKDSQRYK
                                                 VDYESQSTDT       QNFSSESKRE         TEYGPCRREM      EDTLNHLKFL
                                                 NVLSPRGVHI       PNCDKKGFYK         KKQCRPSKGR      KRGFCWCVDK
                                                 YGQPLPGYTT       KGKEDVHCYS         MQSK



 milataxelum
 milataxel                                   1,10β-dihydroxy-9-oxo-5β,20-epoxy-3ζ-tax-11-ene-2α,4,7β,13α-
                                             tetrayl 4-acetate 2-benzoate 13-[(2R,3R)-3-(tert-
                                             butoxycarbonylamino)-3-(furan-2-yl)-2-hydroxypropanoate]
                                             7-propanoate

 milataxel                                   12b-acétate, 12-benzoate, 9-[(2R,3R)-3-[[(1,1-
                                             diméthyléthoxy)carbonyl]amino]-3-(furan-2-yl)-2-hydroxypropanoate]
                                             et 4-propanoate de (2aR,4S,4aS,6R,7E,9S,11S,12S,12bS)-6,11-
                                             dihydroxy-4a,8,13,13-tétraméthyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-
                                             décahydro-7,11-méthano-1H-cyclodéca[3,4]benzo[1,2-b]oxète-
                                             4,9,12,12b(2aH)-tétrayle

 milataxel                                   12b-acetato, 12-benzoato, 9-[(2R,3R)-3-[[(1,1-
                                             dimetiletoxi)carbonil]amino]-3-(furan-2-il)-2-hidroxipropanoato] y
                                             4-propanoato de (2aR,4S,4aS,6R,7E,9S,11S,12S,12bS)-6,11-
                                             dihidroxi-4a,8,13,13-tetrametil-5-oxo-3,4,4a,5,6,9,10,11,12,12a-
                                             decahidro-7,11-metano-1H-ciclodeca[3,4]benzo[1,2-b]oxeto-
                                             4,9,12,12b(2aH)-tetrail



                                                                                                                      85
Recommended INN: List 53                                   WHO Drug Information, Vol. 19, No. 1, 2005




                           C44H55NO16

                                                                                  O
                                                               H      O                   CH3
                                                         HO                  O
                                                 H3C                      CH3 H
                                O     H OH
                                                O                  CH3
                                                                              H       H
                                                H                  CH3
                                    H NH O
                                O                                         O           O
                                                         HO
                                       O                        H O
                              H3C                                  O          CH3
                              H3C
                                       CH3                          O




 mirococeptum
 mirococept                protein APT070 (synthetic human clone pET04-01 complement
                           receptor type 1 short consensus repeat 1-3 fragment), (198→17')-
                           disulfide with N-(tetradecanoyl)glycyl-L-seryl-L-seryl-L-lysyl-L-seryl-
                           L-prolyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-
                           L-prolylglycyl-L-aspartyl-L-cysteinamide

 mirococept                (238-17')-disulfure entre le [41-méthionyl]précurseur du récepteur de
                           type 1 du complément-(41-238)-peptide et
                           le (N-tétradécanoylglycyl)-L-séryl-L-séryl-L-lysyl-L-séryl-L-prolyl-
                           L-séryl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-prolylglycyl-
                           L-aspartyl-L-cystéinamide

 mirococept                (238-17')-disulfuro entre el [41-metionil]precursor del receptor de tipo
                           1 del complemento -(41-238)- péptido y el (N-tetradecanoilglicil)-
                           L-seril-L-seril-L-lisil-L-seril-L-prolil-L-seril-L-lisil-L-lisil-L-lisil-L-lisil-L-lisil-
                           L-lisil-L-prolilglicil-L-aspartil-L-cisteinamida

                           C1054H1635N293O312S16

                           H MQCNAPEWLP FARPTNLTDE FEFPIGTYLN YECRPGYSGR
                             PFSIICLKNS VWTGAKDRCR RKSCRNPPDP VNGMVHVIKG
                               IQFGSQIKYS CTKGYRLIGS SSATCIISGD TVIWDNETPI
                               CDRIPCGLPP TITNGDFIST NRENFHYGSV VTYRCNPGSG
                               GRKVFELVGE PSIYCTSNDD QVGIWSGPAP QCIIPNKC OH

                                                                          GSSKSPSKKK KKKPGDC NH2
                                        CH3                          O




86
WHO Drug Information, Vol. 19, No. 1, 2005                                                                  Recommended INN: List 53


 paclitaxelum ceribas
 paclitaxel ceribate                         7β-[(2RS)-2,3-dihydroxypropoxycarbonyloxy]-1-hydroxy-9-oxo-
                                             5β,20-epoxytax-11-ene-2α,4,10β,13α-tetrayl 4,10-diacetate
                                             2-benzoate 13-[(2R,3S)-3-benzamido-2-hydroxy-
                                             3-phenylpropanoate]

 céribate de paclitaxel                      6,12b-diacétate, 12-benzoate, 4-[[(2RS)-2,3-dihydroxypropoxy]=
                                             carboxylate] et 9-[(2R,3S)-3-(benzoylamino)-2-hydroxy-
                                             3-phénylpropanoate] de
                                             (2aR,4S,4aS,6R,7E,9S,11S,12S,12aR,12bS)-11-hydroxy-
                                             4a,8,13,13-tétraméthyl-5-oxo-3,4,4a,5,6,9,10,11,12,12a-décahydro-
                                             7,11-méthano-1H-cyclodéca[3,4]benzo[1,2-b]oxète-
                                             4,6,9,12,12b(2aH)-pentayle

 ceribato de paclitaxel                      6,12b-diacetato, 12-benzoato, 4-[[(2RS)-2,3-dihidroxipropoxi]=
                                             carboxilato] y 9-[(2R,3S)-3-(benzoilamino)-3-fenilpropanoato-
                                             2-hidroxi] de (2aR,4S,4aS,6R,7E,9S,11S,12S,12aR,12bS)-11-
                                             hidroxi-4a,8,13,13-tetrametil-5-oxo-3,4,4a,5,6,9,10,11,12,12a-
                                             decahidro-7,11-metano-1H-ciclodeca[3,4]benzo[1,2-b]oxeto-
                                             4,6,9,12,12b(2aH)-pentailo

                                             C51H57NO18

                                                                              O       CH3               O
                                                                                      H     O
                                                                                  O                O  O          *     OH
                                                                      H3C                       CH3 H
                                                         H OH                                                   H OH
                                                                      O                   CH3
                                                                                                    H       H        and epimer at C*
                                                                      H                   CH3
                                                    HN    H       O                                                  et l'épimère en C*
                                                              O                                 O           O        y el epímero en el C*
                                                                                  OH        H
                                                                                          O O       CH3

                                                                                      O




 palosuranum
 palosuran                                   1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)ethyl]-3-(2-methylquinolin-
                                             4-yl)urea

 palosuran                                   1-[2-(4-benzyl-4-hydroxypipéridin-1-yl)éthyl]-3-(2-méthylquinoléin-
                                             4-yl)urée

 palosurán                                   1-[2-(4-bencil-4-hidroxipiperidin-1-il)etil]-3-(2-metilquinolin-4-il)urea

                                             C25H30N4O2

                                                    CH3
                                                                                            OH
                                                N                 O
                                                                                      N
                                                              N           N
                                                              H           H




                                                                                                                                         87
Recommended INN: List 53                             WHO Drug Information, Vol. 19, No. 1, 2005


 panitumumabum
 panitumumab               immunoglobulin, anti-(human epidermal growth factor receptor)
                           (human monoclonal ABX-EGF heavy chain), disulfide with human
                           monoclonal ABX-EGF light chain, dimer

 panitumumab               immunoglobuline, anti-(récepteur du facteur de croissance épidermal
                           humain) dimére du disulfure entre la chaîne lourde et la chaîne
                           légère de l'anticorps monoclonal humain ABX-EGF

 panitumumab               inmunoglobulina, anti-(receptor del factor de crecimiento epidérmico
                           humano) dímero del disulfuro entre la cadena pesada y la cadena
                           ligera del anticuerpo monoclonal humano ABX-EGF

                           C6306H9732N1672O1994S46



 pegamotecanum
 pegamotecan               α-{2-[(2S)-1-{[(4S)-4-ethyl-3,14-dioxo-3,4,12,14-tetrahydro-
                           1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl]oxy}-1-oxopropan-
                           2-ylamino]-2-oxoethyl}-ω-(2-[(2S)-1-{[(4S)-4-ethyl-3,14-dioxo-
                           3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-
                           4-yl]oxy}-1-oxopropan-2-ylamino]-2-oxoethoxy)poly(oxyethane-
                           1,2-diyl)

 pégamotécan               dérivé pégylé de la camptothécine obtenu par amidification entre le
                           (2S)-2-aminopropanoate de (4S)-4-éthyl-3,14-dioxo-3,4,12,14-
                           tétrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoléin-4-yle
                           (L-alaninate de camptothécine) et le α-(carboxyméthyl)-
                           ω-(carboxyméthoxy)poly(oxyéthylène)

 pegamotecán               derivado pegilado de la camptotecina obtenido por amidificación
                           entre el (2S)-2-aminopropanoato de (4S)-4-etil-3,14-dioxo-3,4,12,14-
                           tetrahidro-1H-pirano[3',4':6,7]indolizino[1,2-b]quinolin-4-ilo
                           (L-alaninato de camptotecina) y el α-(carboximetil)-
                           ω-(carboximetoxi)poli(oxietileno)

                           C50H44N6O13 [C2H4O]n

                                              O
                                                                                            O
                                          N              O
                                                                                        N            O
                                                             O
                                     N                   O                                                O
                                                                 H                  N
                                              H3C                                           O   O
                                                     O               CH 3               O             CH3
                                                         HN                     O                   CH3
                                                                            O               N
                                                                                n
                                                                                            H   H
                                                                 O



 pelitinibum
 pelitinib                 (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-
                           7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide

 pélitinib                 (2E)-N-[4-[(3-chloro-4-fluorophényl)amino]-3-cyano-
                           7-éthoxyquinoléin-6-yl]-4-(diméthylamino)but-2-énamide

 pelitinib                 (2E)-N-[4-[(3-cloro-4-fluorofenil)amino]-3-ciano-7-etoxiquinolin-6-il]-
                           4-(dimetilamino)but-2-enamida


88
WHO Drug Information, Vol. 19, No. 1, 2005                                                   Recommended INN: List 53


                                             C24H23ClFN5O2

                                                               H3C        O        N


                                                       CH3               HN            CN
                                                       N                          HN        Cl
                                             H3C                              O

                                                                                            F

 perflubutanum
 perflubutane                                1,1,1,2,2,3,3,4,4,4-decafluorobutane

 perflubutane                                décafluorobutane

 perflubutano                                decafluorobutano

                                             C4F10

                                                   F       F
                                                                CF3
                                             F3C
                                                       F       F



 perzinfotelum
 perzinfotel                                 [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]=
                                             phosphonic acid

 perzinfotel                                 acide [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-én-2-yl)éthyl]=
                                             phosphonique

 perzinfotel                                 ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)etil]=
                                             fosfónico

                                             C9H13N2O5P

                                                       O

                                                                     O
                                             HN
                                                                          OH
                                                           N
                                                                         P OH
                                                                         O



 prasugrelum
 prasugrel                                   5-[(1RS)-2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-
                                             4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate

 prasugrel                                   acétate de 5-[(1RS)-2-cyclopropyl-1-(2-fluorophényl)-2-oxoéthyl]-
                                             4,5,6,7-tétrahydrothiéno[3,2-c]pyridin-2-yle

 prasugrel                                   acetato de 5-[(1RS)-2-ciclopropil-1-(2-fluorofenil)-2-oxoetil]-
                                             4,5,6,7-tetrahidrotieno[3,2-c]piridin-2-ilo




                                                                                                                   89
Recommended INN: List 53                                        WHO Drug Information, Vol. 19, No. 1, 2005


                           C20H20FNO3S


                                                           F
                                                               H            and enantiomer
                                      O
                                                                            et énantiomère
                           H3C                                              y enantiómero
                                                            N
                                      O
                                                                    O
                                              S



 radafaxinum
 radafaxine                (2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethylmorpholin-2-ol

 radafaxine                (+)-(2S,3S)-2-(3-chlorophényl)-3,5,5-triméthylmorpholin-2-ol

 radafaxina                (+)-(2S,3S)-2-(3-clorofenil)-3,5,5-trimetilmorfolin-2-ol

                           C13H18ClNO2

                                                   CH3
                                          O         CH3
                                 HO
                                                  NH

                                          H CH3

                                Cl



 ranirestatum
 ranirestat                (3R)-2'-(4-bromo-2-fluorobenzyl)spiro[pyrrolidine-
                           3,4'(1'H)-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetrone

 ranirestat                (-)-(3R)-2'-(4-bromo-2-fluorobenzyl)spiro[pyrrolidine-
                           3,4'(1'H)-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tétrone

 ranirestat                (-)-(3R)-2'-(4-bromo-2-fluorobencil)espiro[pirrolidina-
                           3,4'(1'H)-pirrolo[1,2-a]pirazina]-1',2,3',5(2'H)-tetrona

                           C17H11BrFN3O4

                                                  O
                                                           NH

                                                                O
                           Br                 O
                                                           N
                                                  N

                                      F                O



 regadenosonum
 regadenoson               1-(6-amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-N-methyl-1H-pyrazole-
                           4-carboxamide

 régadénoson               1-(6-amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-N-méthyl-1H-pyrazole-
                           4-carboxamide

 regadenosón               1-(6-amino-9-β-D-ribofuranosil-9H-purin-2-il)-N-metil-1H-pirazol-
                           4-carboxamida


90
WHO Drug Information, Vol. 19, No. 1, 2005                                                             Recommended INN: List 53


                                             C15H18N8O5

                                                                            NH2

                                                                        N           N
                                                     O
                                                                    N       N       N
                                             H3C     NH             N
                                                               HO
                                                                            O




                                                                         OH     OH



 reparixinum
 reparixin                                   (2R)-2-[4-(2-methylpropyl)phenyl]-N-methylsulfonylpropanamide

 réparixine                                  (-)-(2R)-2-[4-(2-méthylpropyl)phényl]-N-(méthylsulfonyl)propanamide

 reparixina                                  (-)-(2R)-2-[4-(2-metilpropil)fenil]-N-(metilsulfonil)propanamida

                                             C14H21NO3S

                                                                        H CH3 H
                                                                              N          CH3
                                                     CH3                             S
                                                                            O     O O
                                             H3C



 retapamulinum
 retapamulin                                 (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-
                                             tetramethyl-1-oxodecahydro-3a,9-propanocyclopenta[8]annulen-
                                             8-yl{[(1R,3s,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-
                                             yl]sulfanyl}acetate

 rétapamuline                                [[(1R,3s,5S)-8-méthyl-8-azabicyclo[3.2.1]oct-3-yl]sulfanyl]acétate de
                                             (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-éthényl-5-hydroxy-4,6,9,10-
                                             tétraméthyl-1-oxodécahydro-3a,9-propano-3aH-
                                             cyclopenta[8]annulén-8-yle

 retapamulina                                [[(1R,3s,5S)-8-metyl-8-azabiciclo[3.2.1]oct-3-il]sulfanil]acetato de
                                             (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-etenil-5-hidroxi-4,6,9,10-
                                             tetrametil-1-oxodecahidro-3a,9-propano-3aH-ciclopenta[8]anulen-
                                             8-ilo

                                             C30H47NO4S

                                                           H
                                                                                             H
                                                                                                 CH3
                                                                    H               H H3C
                                               H3C    N                         O                 O
                                                                    S
                                                                            O            H
                                                           H
                                                                         H3C
                                                                        H2C
                                                                                HO H H CH3




                                                                                                                            91
Recommended INN: List 53                                      WHO Drug Information, Vol. 19, No. 1, 2005


 revaprazanum
 revaprazan                N-(4-fluorophenyl)-4,5-dimethyl-6-[(1RS)-1-methyl-
                           3,4-dihydroisoquinolin-2(1H)-yl]pyrimidin-2-amine

 révaprazan                N-(4-fluorophényl)-4,5-diméthyl-6-[(1RS)-1-méthyl-
                           3,4-dihydroisoquinoléin-2(1H)-yl]pyrimidin-2-amine

 revaprazán                N-(4-fluorofenil)-4,5-dimetil-6-[(1RS)-1-metil-3,4-dihidroisoquinolin-
                           2(1H)-il]pirimidin-2-amina

                           C22H23FN4


                                          CH3
                                           H
                                                        H                    and enantiomer
                                      N         N       N                    et énantiomère
                                                                             y enantiómero
                                                    N
                                  H3C                                   F
                                                CH3



 rilpivirinum
 rilpivirine               4-{[4-({4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-
                           2-yl]amino}benzonitrile

 rilpivirine               4-[[4-[[4-[(1E)-2-cyanoéthényl]-2,6-diméthylphényl]amino]pyrimidin-
                           2-yl]amino]benzonitrile

 rilpivirina               4-[[4-[[4-[(1E)-2-cianoetenil]-2,6-dimetilfenil]amino]pirimidin-
                           2-il]amino]benzonitrilo

                           C22H18N6

                           N
                                                        CH3                          CN
                                                                   N

                                                        N      N       N
                                                        H              H
                                                CH3



 ritobegronum
 ritobegron                [4-(2-{[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino}=
                           ethyl)-2,5-dimethylphenoxy]acetic acid

 ritobégron                acide [4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphényl)-1-méthyléthyl]=
                           amino]éthyl]-2,5-diméthylphénoxy]acétique

 ritobegrón                ácido [4-[2-[[(1R,2S)-1-hidroxi-1-(4-hidroxifenil)prop-2-il]amino]etil]-
                           2,5-dimetilfenoxi]acético

                           C21H27NO5

                                           H OH H                      CH3
                                                N

                                                H CH3
                           HO                                                 O     CO2H
                                                                       CH3



92
WHO Drug Information, Vol. 19, No. 1, 2005                                                   Recommended INN: List 53


 robenacoxibum
 robenacoxib                                 {5-ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid

 robénacoxib                                 acide [5-éthyl-2-[(2,3,5,6-tétrafluorophényl)amino]phényl]acétique

 robenacoxib                                 ácido [5-etil-2-(2,3,5,6-tetrafluoroanilino)fenil]acético

                                             C16H13F4NO2

                                             H3C                           CO2H

                                                                      NH
                                                          F                  F


                                                          F                  F



 rostafuroxinum
 rostafuroxin                                  21,23-epoxy-24-nor-14β,5β-chola-20,21-diene-3β,14,17α-triol

 rostafuroxine                                 17-(furan-3-yl)-5β,14β-androstane-3β,14,17α-triol

 rostafuroxina                                 17-(furan-3-il)-5β,14β-androstano-3β,14,17α-triol

                                               C23H34O4

                                                                                  O

                                                                            CH3
                                                                                  OH
                                                              CH3      H

                                                                  H         OH
                                               HO
                                                    H         H

 selodenosonum
 selodenoson                                   1-[6-(cyclopentylamino)-9H-purin-9-yl]-1-deoxy-N-ethyl-
                                               β-D-ribofuranuronamide

 sélodénoson                                   1-[6-(cyclopentylamino)-9H-purin-9-yl]-1-désoxy-N-éthyl-
                                               β-D-ribofuranuronamide

 selodenosón                                   1-[6-(ciclopentilamino)-9H-purin-9-il]-1-desoxi-N-etil-
                                               β-D-ribofuranuronamida

                                               C17H24N6O4



                                                                  HN

                                                                             N
                                                                  N

                                                                      N      N
                                                        H
                                               H3C      N         O
                                                                      O




                                                                  OH       OH


                                                                                                                  93
Recommended INN: List 53                                   WHO Drug Information, Vol. 19, No. 1, 2005




 taltobulinum
 taltobulin                (2E,4S)-4-{(2S)-N,3,3-trimethyl-2-[(2S)-3-methyl-2-(methylamino)-
                           3-phenylbutanamido]butanamido}-2,5-dimethylhex-2-enoic acid

 taltobuline               acide (2E,4S)-4-[[(2S)-3,3-diméthyl-2-[[(2S)-3-méthyl-
                           2-(méthylamino)-3-phénylbutanoyl]amino]butanoyl]méthylamino]-
                           2,5-diméthylhex-2-énoïque

 taltobulina               ácido (2E,4S)-4-{(2S)-N,3,3-trimetil-2-[(2S)-3-metil-2-(metilamino)-
                           3-fenilbutanamido]butanamido}-2,5-dimetilhex-2-enoico

                           C27H43N3O4

                                                CH3
                                        H3C
                                                 CH3
                                        O           CH3
                                 H          H
                                 N                    N                CO2H
                           H3C            N
                                        H H                   H
                              H3C                   O           CH3
                                                    H 3C      CH3
                               H3 C



 tandutinibum
 tandutinib                4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-
                           N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide

 tandutinib                4-[6-méthoxy-7-[3-(pipéridin-1-yl)propoxy]quinazolin-4-yl]-
                           N-[4-(1-méthyléthoxy)phényl]pipérazine-1-carboxamide

 tandutinib                4-[6-metoxi-7-[3-(piperidin-1-il)propoxi]quinazolin-4-il]-
                           N-[4-(1-metiletoxi)fenil]piperazina-1-carboxamida

                           C31H42N6O4

                                                       N       N

                                                                   N
                                                                                  H
                                                                         N        N
                                 N              O                                                  CH3
                                                       OCH3                   O
                                                                                               O     CH3


 teglicarum
 teglicar                  (3R)-3-[(tetradecylaminocarbonylamino]-4-(trimethylazaniumyl)=
                           butanoate

 téglicar                  (3R)-3-[(tétradécylcarbamoyl)amino]-4-(triméthylammonio)butanoate

 teglicar                  (3R)-3-[(tetradecilcarbamoil)amino]-4-(trimetilamonio)butanoato

                           C22H45N3O3

                                                                                            CO2-
                                                                                      O      H CH3
                                                                                                 N+ CH3
                           H3C                                                    N       N
                                                                                  H       H       CH3




94
WHO Drug Information, Vol. 19, No. 1, 2005                                                               Recommended INN: List 53


 telavancinum
 telavancin                                  (3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-
                                             10,19-dichloro-44-[(3-{[2-(decanylamino)ethyl]amino}-2,3,6-trideoxy-
                                             3-C-methyl-α-L-lyxo-hexopyranosyl-(1→2)-β-D-glucopyranosyl)oxy]-
                                             7,22,28,30,32-pentahydroxy-6-[(2R)-4-methyl-2-(methylamino)=
                                             pentanamido]-2,5,24,38,39-pentaoxo-29-{[(phosphonomethyl)=
                                             amino]methyl}-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-
                                             1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-
                                             bis(metheno)[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]=
                                             benzoxadiazacyclotetracosine-26-carboxylic acid

 télavancine                                 acide (3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoéthyl)-
                                             10,19-dichloro-44-[[2-O-[3-[[2-(décylamino)éthyl]amino]-
                                             2,3,6-tridésoxy-3-C-méthyl-α-L-lyxo-hexopyranosyl]-
                                             β-D-glucopyranosyl]oxy]-7,22,28,30,32-pentahydroxy-
                                             6-[[(2R)-4-méthyl-2-(méthylamino)pentanoyl]amino]-2,5,24,38,39-
                                             pentaoxo-29-[[(phosphonométhyl)amino]méthyl]-
                                             2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tétradécahydro-
                                             23,36-(épiminométhano)-8,11:18,21-diéthéno-22H-13,16:31,35-
                                             diméthéno-1H,13H-[1,6,9]oxadiazacyclohexadécino=
                                             [4,5-m][10,2,16]benzoxadiazacyclotétracosine-26-carboxylique

 telavancina                                 ácido (3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoetil)-
                                             10,19-dicloro-44-[[2-O-[3-[[2-(decilamino)etil]amino]-2,3,6-tridesoxi-
                                             3-C-metil-α-L-lixo-hexopiranosil]-β-D-glucopiranosil]oxi]-
                                             7,22,28,30,32-pentahidroxi-6-[[(2R)-4-metil-2-(metilamino)=
                                             pentanoil]amino]-2,5,24,38,39-pentaoxo-29-[[(fosfonometil)amino]=
                                             metil]-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahidro-
                                             23,36-(epiminometano)-8,11:18,21-dieteno-22H-13,16:31,35-
                                             dimeteno-1H,13H-[1,6,9]oxadiazaciclohexadecino=
                                             [4,5-m][10,2,16]benzoxadiazaciclotetracosina-26-carboxílico

                                             C80H106Cl2N11O27P

                                                                   O
                                                          H
                                                          N        P OH
                                                                    OH
                                             HO               OH
                                                                OH


                                                          H                                    NH2             H 3C
                                                  HN                                   O                                  CH3
                                                          CO2H              O                        O
                                                                                           H                          H
                                                        H H             H        H H                     H H
                                                          N                        N                       N                CH3
                                               O                        N                      N                       N
                                                                        H                      H                       H
                                                              O                        O                        O
                                               HO                                                           H
                                                    H                                                      OH
                                                                        O              O
                                                                            OH
                                                              Cl                 O             Cl
                                                                            O
                                                                       OH
                                                               HO
                                                                        O
                                                                            O
                                                                  CH3
                                                                  CH3
                                                          HO

                                                              HN
                                                                                N                                     CH3
                                                                                H


                                                                                                                                  95
Recommended INN: List 53                                 WHO Drug Information, Vol. 19, No. 1, 2005




 tifuvirtidum
 tifuvirtide               N-acetyl-L-tryptophyl-L-glutaminyl-L-glutamyl-L-tryptophyl-L-glutamyl-
                           L-glutaminyl-L-lysyl-L-isoleucyl-L-threonyl-L-alanyl-L-leucyl-L-leucyl-
                           L-glutamyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-isoleucyl-L-glutaminyl-
                           L-glutaminyl-L-glutamyl-L-lysyl-L-asparagyl-L-glutamyl-L-tyrosyl-
                           L-glutamyl-L-leucyl-L-glutaminyl-L-lysyl-L-leucyl-L-aspartyl-L-lysyl-
                           L-tryptophyl-L-alanyl-L-seryl-L-leucyl-L-tryptophyl-L-glutamyl-
                           L-tryptophyl-L-phenylalaninamide

 tifuvirtide               acétyl-L-tryptophyl-L-glutaminyl-L-glutamyl-L-tryptophyl-L-glutamyl-
                           L-glutaminyl-L-lysyl-L-isoleucyl-L-thréonyl-L-alanyl-L-leucyl-L-leucyl-
                           L-glutamyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-isoleucyl-L-glutaminyl-
                           L-glutaminyl-L-glutamyl-L-lysyl-L-asparaginyl-L-glutamyl-L-tyrosyl-
                           L-glutamyl-L-leucyl-L-glutaminyl-L-lysyl-L-leucyl-L-aspartyl-L-lysyl-
                           L-tryptophyl-L-alanyl-L-séryl-L-leucyl-L-tryptophyl-L-glutamyl-
                           L-tryptophyl-L-phénylalaninamide

 tifuvirtida               acetil-L-triptofil-L-glutaminil-L-glutamil-L-triptofil-L-glutamil-
                           L-glutaminil-L-lisil-L-isoleucil-L-treonil-L-alanil-L-leucil-L-leucil-
                           L-glutamil-L-glutaminil-L-alanil-L-glutaminil-L-isoleucil-L-glutaminil-
                           L-glutaminil-L-glutamil-L-lisil-L-asparaginil-L-glutamil-L-tirosil-
                           L-glutamil-L-leucil-L-glutaminil-L-lisil-L-leucil-L-aspartil-L-lisil-L-triptofil-
                           L-alanil-L-seril-L-leucil-L-triptofil-L-glutamil-L-triptofil-L-fenilalaninamida

                           C235H341N57O67

                                O
                                    Trp Gln Glu Trp Glu Gln Lys Ile Thr          Ala Leu    Leu Glu
                                                                                  10
                           H3C
                                    Gln Ala Gln Ile Gln Gln Glu Lys Asn Glu Tyr Glu Leu
                                                                  20
                                    Gln Lys Leu Asp Lys Trp Ala Ser Leu Trp Glu Trp Phe NH2
                                                    30




 tilargininum
                            5
 tilarginine               N -(methylamidino)-L-ornithine

 tilarginine               acide (2S)-2-amino-5-(3-méthylguanidino)pentanoïque
                            5
 tilarginina               N -(metilamidino)-L-ornitina

                           C7H16N4O2

                                    H        H      H    NH2
                                    N        N
                           H3C                            CO2H
                                        NH

 topilutamidum
 topilutamide              (2RS)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-
                           3-[(trifluoroacetyl)amino]propanamide

 topilutamide              (2RS)-2-hydroxy-2-méthyl-N-[4-nitro-3-(trifluorométhyl)phényl]-
                           3-[(trifluoroacétyl)amino]propanamide

 topilutamida              (2RS)-2-hidroxi-2-metil-N-[4-nitro-3-(trifluorometil)fenil]-
                           3-[(trifluoroacetil)amino]propanamida




96
WHO Drug Information, Vol. 19, No. 1, 2005                                                 Recommended INN: List 53


                                             C13H11F6N3O5

                                                        H HO   CH3 H
                                             F 3C       N          N         CF3       and enantiomer
                                                                                       et énantiomère
                                                    O           O                      y enantiómero
                                                                             NO2


 torapselum
 torapsel                                    42-89-glycoprotein (human clone PMT21:PL85 P-selectin
                                             glycoprotein ligand fusion protein with immunoglobulin (human
                                             constant region)

 torapsel                                    dimère de la protéine de fusion de la [48-proline]glycoprotéine
                                             (ligand 1 de la sélectine-P humaine)-(1-48)-peptide avec le peptide
                                             de 224 résidus, partie C-terminale de la chaîne lourde de
                                             l'immunoglobuline G1 humaine

 torapsel                                    dímero de la proteína de fusión de la [48-prolina]glicoproteína
                                             (ligando 1 de la selectina-P humana)-(1-48)-péptido con el péptido
                                             de 224 residuos, parte C-terminal de la cadena pesada de la
                                             inmunoglobulina G1 humana

                                             C2726H4186N710O846S20

                                              QATEYEYLDY            DFLPETEPPE
                                              MLRNSTDTTP            LTGPGTPEST
                                              TVEPAARPHT            CPPCPAPEAL
                                              GAPSVFLFPP            KPKDTLMISR
                                              TPEVTCVVVD            VSHEDPEVKF
                                              NWYVDGVEVH            NAKTKPREEQ
                                              YNSTYRVVSV            LTVLHQDWLN
                                              GKEYKCKVSN            KALPVPIEKT
                                              ISKAKGQPRE            PQVYTLPPSR
                                              EEMTKNQVSL            TCLVKGFYPS
                                              DIAVEWESNG            QPENNYKTTP
                                              PVLDSDGSFF            LYSKLTVDKS
                                              RWQQGNVFSC            SVMHEALHNH
                                              YTQKSLSLSP            GK
                                                                                   2




 trodusqueminum
 trodusquemine                               (24R)-3β-{[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]amino}-
                                             7α-hydroxy-5α-cholestan-24-yl hydrogen sulfate

 trodusquémine                               hydrogénosulfate de (24R)-3β-[[3-[[4-[(3-aminopropyl)amino]butyl]=
                                             amino]propyl]amino]-7α-hydroxy-5α-cholestan-24-yle

 trodusquemina                               hidrogénosulfato de (24R)-3β-[[3-[[4-[(3-aminopropil)amino]butil]=
                                             amino]propil]amino]-7α-hidroxi-5α-colestan-24-ilo




                                                                                                                   97
Recommended INN: List 53                                       WHO Drug Information, Vol. 19, No. 1, 2005


                           C37H72N4O5S

                                                                                       H3C H       H
                                                                                                       OSO3H
                                                                                        CH3
                                                                                               H         CH3
                                            H                              CH3     H
                                            N                                                      H3C
                                                      HN
                                                                               H        H
                           H 2N
                                                                  N                     OH
                                                                  H H      H       H



 vandetanibum
 vandetanib                N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-
                           4-yl)methoxy]quinazolin-4-amine

 vandétanib                N-(4-bromo-2-fluorophényl)-6-méthoxy-7-[(1-méthylpipéridin-
                           4-yl)méthoxy]quinazolin-4-amine

 vandetanib                N-(4-bromo-2-fluorofenil)-7-[(1-metilpiperidin-4-il)metoxi]-
                           6-metoxiquinazolin-4-amina

                           C22H24BrFN4O2

                                                                       F           Br
                                                           N       N

                                                                       N
                                                                       H
                                                      O
                                    N                      OCH3
                           H3C



 vestipitantum
 vestipitant               (2S)-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-
                           2-methylphenyl)-N-methylpiperazine-1-carboxamide

 vestipitant               (+)-(2S)-N-[(1R)-1-[3,5-bis(trifluorométhyl)phényl]éthyl]-2-(4-fluoro-
                           2-méthylphényl)-N-méthylpipérazine-1-carboxamide

 vestipitant               (+)-(2S)-N-[(1R)-1-[3,5-bis(trifluorometil)fenil]etil]-2-(4-fluoro-
                           2-metilfenil)-N-metilpiperazina-1-carboxamida

                           C23H24F7N3O

                                                            CF3

                               HN                 CH3
                                        N         N
                                                                    CF3
                                        H     O    H CH3
                                            CH3

                           F




98
WHO Drug Information, Vol. 19, No. 1, 2005                                                      Recommended INN: List 53




                             AMENDMENTS TO PREVIOUS LISTS
                     MODIFICATIONS APPORTÉES AUX LISTES ANTÉRIEURES
                         MODIFICACIONES A LAS LISTAS ANTERIORES


Recommended International Nonproprietary Names (Rec. INN): List 51
Dénominations communes internationales recommandées (DCI Rec.): Liste 51
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 51
(WHO Drug Information, Vol. 18, No. 1, 2004)

p. 94    eptoterminum alfa
         eptotermin alfa                replace the graphic formula by:
         eptotermine alfa               remplacer la formule développée par:
         eptotermina alfa               sustitúyase la fórmula desarrollada por la siguiente:

                                        STGSKQRSQN         RSKTPKNQEA          LRMANVAENS          SSDQRQACKK

                                        HELYVSFRDL          GWQDWIIAPE         GYAAYYCEGE          CAFPLNSYMN

                                        ATNHAIVQTL         VHFINPETVP          KPCCAPTQLN          AISVLYFDDS
                                        SNVILKKYRN          MVVRACGCH


Recommended International Nonproprietary Names (Rec. INN): List 52
Dénominations communes internationales recommandées (DCI Rec.): Liste 52
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 52
(WHO Drug Information, Vol. 18, No. 3, 2004)



p. 248   beminafilum
         beminafil                      replace the graphic formula by the following:
         béminafil                      remplacer la formule développée par la suivante:
         beminafilo                     sustitúyase la fórmula desarrollada por la siguiente:



                                                                S

                                                                     N

                                                           N     N
                                                           H
                                        H3CO                                    CO2H
                                                  Cl

p. 264   zanolimumabum
         zanolimumab                    delete the graphic formula
         zanolimumab                    supprimer la formule développée
         zanolimumab                    suprímase la fórmula desarrollada




                                                                                                                     99
 Recommended INN: List 53                                                WHO Drug Information, Vol. 19, No. 1, 2005




Procedure and Guiding Principles / Procédure et Directives / Procedimientos y principios generales
The text of the Procedures for the Selection of Recommended International Nonproprietary Names for Pharmaceutical
Substances and General Principles for Guidance in Devising International Nonproprietary Names for Pharmaceutical
Substances will be reproduced in proposed INN lists only.
Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour les
substances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationales
applicables aux substances pharmaceutiques seront publiés seulement dans les listes des DCI proposées.
El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustancias
farmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales para
sustancias farmacéuticas aparece solamente en las listas de DCI propuestas.




 100
